Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Renal Cell
  • Hypertension
  • Indoles
  • Kidney Neoplasms
  • Neutropenia
  • Pyrroles

abstract

  • On-treatment neutropenia and hypertension are independent biomarkers of sunitinib efficacy and may add prognostic accuracy to the IMDC model.

publication date

  • December 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4705883

Digital Object Identifier (DOI)

  • 10.1038/bjc.2015.368

PubMed ID

  • 26492223

Additional Document Info

start page

  • 1571

end page

  • 80

volume

  • 113

number

  • 11